<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12.3: Neuroinflammation: Microglial Activation and Cognitive Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Neuro/PNI */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ddd6fe 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffaf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            color: #4c1d95;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f9fafb;
            padding: 25px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #4c1d95;
            font-weight: 700;
            margin-bottom: 15px;
            text-transform: uppercase;
            font-size: 14px;
        }

        /* References */
        .references-box {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .footer-logo {
            max-width: 120px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: The Neuro-Immune-Endocrine Axis</p>
            <h1 class="lesson-title">Neuroinflammation: Microglial Activation and Cognitive Health</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Sentinels: Microglial States</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Leaky Brain: BBB Permeability</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The NLRP3 Inflammasome</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Clinical Presentations</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Data-Driven Biomarkers</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The B.R.I.D.G.E. Protocol</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between homeostatic and "primed" microglial states in the CNS.</li>
                <li>Analyze the molecular triggers of Blood-Brain Barrier (BBB) breakdown and "Leaky Brain."</li>
                <li>Explain the role of the NLRP3 inflammasome in perpetuating chronic neuroinflammation.</li>
                <li>Identify key clinical red flags for neuroinflammation, from brain fog to neurodegeneration.</li>
                <li>Utilize functional biomarkers to assess central nervous system inflammation and oxidative stress.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>From Systemic to Central: The Inflammatory Bridge</h3>
            <p>In our previous lesson, we explored how the HPA axis and the peripheral immune system engage in a constant feedback loop. Today, we cross the Blood-Brain Barrier. For decades, the brain was considered "immunologically privileged"â€”an isolated fortress. We now know this is false. The brain has its own resident immune system, and when it is triggered, the result is <span class="highlight">neuroinflammation</span>, the silent driver behind the modern epidemic of cognitive decline and mental health disorders.</p>
        </div>

        <h2 id="section1">1. The Sentinels: Microglial Activation and "Priming"</h2>
        <p>Microglia are the resident macrophages of the Central Nervous System (CNS), accounting for approximately <span class="highlight">10-15% of all cells</span> in the brain. Unlike peripheral immune cells, microglia are long-lived and possess a "memory" of previous inflammatory insults.</p>
        
        <p>Microglia exist in a spectrum of states, but for clinical utility, we focus on the transition from a "surveying" (homeostatic) state to an "activated" state. However, the most critical concept for the Integrative Practitioner is <span class="highlight">Microglial Priming</span>. A primed microglial cell is like a loaded gun; it has been previously sensitized by stress, trauma, or systemic inflammation. When a secondary trigger occurs, these cells release an exaggerated, neurotoxic storm of cytokines.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Homeostatic Microglia (M2-like)</th>
                        <th>Activated/Primed Microglia (M1-like)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Function</strong></td>
                        <td>Synaptic pruning, debris clearance, BDNF secretion</td>
                        <td>Pro-inflammatory cytokine release (IL-1Î², TNF-Î±)</td>
                    </tr>
                    <tr>
                        <td><strong>Morphology</strong></td>
                        <td>Ramified (long, thin processes)</td>
                        <td>Amoeboid (retracted processes, swollen body)</td>
                    </tr>
                    <tr>
                        <td><strong>Effect on Neurons</strong></td>
                        <td>Neuroprotective, supports plasticity</td>
                        <td>Neurotoxic, induces synaptic loss</td>
                    </tr>
                    <tr>
                        <td><strong>Clinical State</strong></td>
                        <td>Cognitive clarity, emotional resilience</td>
                        <td>Brain fog, depression, cognitive decline</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section2">2. Leaky Brain: Mechanisms of BBB Permeability</h2>
        <p>The Blood-Brain Barrier (BBB) is a highly selective semipermeable border of endothelial cells. In the <span class="highlight">B.R.I.D.G.E. Methodâ„¢</span>, we view the BBB as the "Gatekeeper." When this gate is compromisedâ€”often referred to as "Leaky Brain"â€”substances that should never reach the CNS (like LPS, heavy metals, and undigested proteins) flood the brain environment.</p>

        <p>The mechanisms of "Leaky Brain" mirror those of "Leaky Gut." Chronic systemic inflammation increases the expression of <span class="highlight">Zonulin</span> in the brain, which disassembles the tight junction proteins (claudins and occludins). A 2022 study published in <i>Nature Communications</i> demonstrated that systemic elevations in IL-6 can directly increase BBB permeability within hours, allowing peripheral immune cells to infiltrate and activate microglia.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">400%</div>
                    <div class="stat-label">Increase in TNF-Î± in "Leaky Brain" states</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3x</div>
                    <div class="stat-label">Risk of Dementia with Chronic BBB Leakage</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">12kDa</div>
                    <div class="stat-label">Size threshold for BBB crossing (Normal)</div>
                </div>
            </div>
        </div>

        <h2 id="section3">3. The NLRP3 Inflammasome: The Molecular Switch</h2>
        <p>At the heart of chronic neuroinflammation lies the <span class="highlight">NLRP3 Inflammasome</span>. This is an intracellular protein complex that acts as a sensor for "danger signals" (DAMPs and PAMPs). Once activated, the NLRP3 inflammasome triggers the maturation of highly inflammatory cytokines, specifically <span class="highlight">IL-1Î² and IL-18</span>.</p>

        <p>In the context of cognitive health, the NLRP3 inflammasome is the bridge between lifestyle triggers and neurodegeneration. Triggers include:</p>
        <ul class="content-list">
            <li><strong>Metabolic Stress:</strong> High glucose and saturated fats (palmitate) activate NLRP3 via mitochondrial ROS.</li>
            <li><strong>Crystalline Structures:</strong> Amyloid-beta plaques and uric acid crystals.</li>
            <li><strong>Environmental Toxins:</strong> Air pollution (particulate matter) and mold mycotoxins.</li>
        </ul>

        <h2 id="section4">4. Clinical Presentations: From Brain Fog to Neurodegeneration</h2>
        <p>Neuroinflammation does not always present as a "disease" initially. It often manifests as subtle functional impairments. In the <span class="highlight">Root Cause Analysis (R)</span> phase of our framework, we look for the "Sickness Behavior" phenotype.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Burned Out" Executive</p>
                    <p class="subtitle">Neuroinflammatory Priming & Cognitive Fatigue</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James, 48</h4>
                        <p>Symptoms: Severe "Brain Fog," loss of executive function, social withdrawal, and "heavy" limbs.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> James had a history of chronic work stress (HPA activation) followed by a severe viral infection 6 months prior. Despite "recovering" from the virus, his cognitive symptoms persisted.</p>
                <p><strong>Intervention:</strong> Using the B.R.I.D.G.E. Method, we identified elevated <i>Quinolinic Acid</i> (a neurotoxic metabolite) and high-sensitivity CRP (3.5 mg/L). His microglia were "primed" by the virus and kept in an activated state by ongoing stress.</p>
                <p><strong>Outcome:</strong> By implementing an NLRP3-inhibiting protocol (High-dose DHA, Luteolin, and Circadian optimization), James reported a <span class="highlight">70% improvement</span> in mental clarity within 8 weeks. His follow-up hs-CRP dropped to 0.8 mg/L.</p>
            </div>
        </div>

        <h2 id="section5">5. Data-Driven Decisions: Biomarkers of CNS Inflammation</h2>
        <p>As an Integrative Practitioner, you must move beyond guesswork. While we cannot easily biopsy the brain, we can use <span class="highlight">surrogate biomarkers</span> to assess the state of the Neuro-Immune axis.</p>

        <h3>Key Biomarkers for the Practitioner:</h3>
        <ul class="content-list">
            <li><strong>Quinolinic Acid (QA):</strong> A metabolite of the kynurenine pathway. Elevated QA is a direct marker of microglial activation and NMDA receptor excitotoxicity.</li>
            <li><strong>S100B:</strong> A protein primarily found in astrocytes. Elevated serum levels indicate BBB disruption and glial distress.</li>
            <li><strong>Homocysteine:</strong> High levels (>10 Âµmol/L) are neurotoxic and contribute to BBB breakdown via oxidative stress.</li>
            <li><strong>Neurofilament Light Chain (NfL):</strong> Often called the "liquid biopsy" of the brain; indicates axonal damage.</li>
        </ul>

        <h2 id="section6">6. The B.R.I.D.G.E. Protocol for Neuroprotection</h2>
        <p>To resolve neuroinflammation, we must address the <strong>Antecedents, Triggers, and Mediators (ATM)</strong> identified in Module 2. The goal is to shift microglia from the M1 (neurotoxic) state back to the M2 (homeostatic) state.</p>

        <div class="principle-card">
            <div class="principle-title">Step 1: Quench the Inflammasome</div>
            <p class="principle-text">Utilize polyphenols like <strong>Apigenin</strong> and <strong>Luteolin</strong>, which have been shown to cross the BBB and inhibit NLRP3 activation. A 2021 meta-analysis found these flavonoids reduce microglial cytokine output by up to 45%.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 2: Seal the Barrier</div>
            <p class="principle-text">Address gut permeability (the Gut-Brain Axis). Use <strong>Butyrate</strong> (a short-chain fatty acid) which strengthens the BBB by upregulating tight junction protein expression.</p>
        </div>

        <div class="principle-card" style="border-left-color: #B8860B;">
            <div class="principle-title">Step 3: Resolve, Don't Just Block</div>
            <p class="principle-text">Use <strong>Specialized Pro-Resolving Mediators (SPMs)</strong>. Unlike NSAIDs, which block inflammation, SPMs signal the microglia to transition into the "cleanup and repair" (M2) phase.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning on neuroinflammatory mechanisms.</p>
            
            <div class="question-item">
                <p class="question-text">1. What is the primary difference between "activated" and "primed" microglia?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Activated microglia are currently responding to a threat. Primed microglia are in a sensitized state due to past insults; they may appear normal but will produce an exaggerated, neurotoxic inflammatory response when triggered by even a minor stressor.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Which biomarker is considered a surrogate for Blood-Brain Barrier (BBB) integrity in a clinical setting?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    S100B is the primary surrogate marker. While it is a glial protein, its presence in the peripheral blood indicates that the BBB has been compromised, allowing CNS proteins to leak out.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Microglia are Dynamic:</strong> They are the brain's primary immune defense and can shift between neuroprotective and neurotoxic states.</li>
                <li><strong>The BBB is a Filter:</strong> Chronic systemic inflammation (from gut or metabolic issues) "pokes holes" in this filter, leading to Leaky Brain.</li>
                <li><strong>NLRP3 is the Target:</strong> This inflammasome is the molecular switch for neuroinflammation and can be modulated by specific phytonutrients and lifestyle changes.</li>
                <li><strong>Data Matters:</strong> Use markers like Quinolinic Acid and S100B to objectively track a client's neuroinflammatory status.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Heneka, M. T., et al. (2018). "Inflammasome activation in Alzheimer's disease." <i>The Lancet Neurology</i>.</li>
                <li>Leng, F., & Edison, P. (2021). "Neuroinflammation and microglial activation in Alzheimerâ€™s disease: where do we go from here?" <i>Nature Reviews Neurology</i>.</li>
                <li>Nimmerjahn, A., et al. (2005). "Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo." <i>Science</i>.</li>
                <li>Pellegrini, C., et al. (2020). "NLRP3 inflammasome in microglia: the gatekeeper of neuroinflammation." <i>Frontiers in Cellular Neuroscience</i>.</li>
                <li>Rhea, E. M., & Banks, W. A. (2019). "Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance." <i>Frontiers in Neuroscience</i>.</li>
                <li>Subhramanyam, C. S., et al. (2019). "Microglia-mediated neuroinflammation in neurodegenerative diseases." <i>Seminars in Cell & Developmental Biology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary B.R.I.D.G.E. Methodâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>